Understanding lymphoma of the stomach, especially among residents of Long Island and surrounding areas, is crucial for effective diagnosis and treatment. This type of cancer can manifest in various forms, notably primary gastric lymphoma, MALT lymphoma, and diffuse large B-cell lymphoma (DLBCL). Gastric MALT lymphoma accounts for 7% to 9% of all B-cell lymphomas and 40% to 50% of primary gastric lymphomas. Each variant involves unique challenges and management strategies that require the expertise of a dedicated gastroenterology practice.
Truly one of the best, he is very well educated and well spoken, he diagnosed me when TWO other gastroenterologists couldn’t. His staff is very friendly as well. His office is also very clean and well taken care of. He cares about his patients and is very deserving of more than 5 stars.
Lymphoma Treatment Options Available on Long Island NY
For those seeking lymphoma treatment in Long Island, our practice offers comprehensive services for managing gastric lymphoma. Our experienced gastroenterologists, including Dr. Mit Shah, MD, who completed his fellowship in Gastroenterology and Hepatology at Nassau UMC, specialize in the evaluation, diagnosis, and treatment of various gastrointestinal disorders. We provide a full spectrum of therapeutic approaches tailored to the specific needs of each patient, ensuring that every individual receives personalized and coordinated care.
Discover Types of Gastric Lymphoma
Gastric lymphoma primarily involves three types:
- Primary Gastric Lymphoma: A type that originates in the stomach’s mucosa and may require tailored treatment approaches.
- MALT Gastric Lymphoma: Often linked with Helicobacter pylori infection, this type can show favorable responses to antibiotic therapy. Approximately 60–90% of early-stage gastric MALT lymphoma cases achieve complete histological response following Helicobacter pylori eradication therapy.
- Diffuse Large B-cell Lymphoma (DLBCL): A more aggressive form that necessitates intensive treatment regimens such as chemotherapy.
Explore Diagnosis Options for Gastric Lymphoma
Accurate and timely diagnosis of gastric lymphoma is paramount. In our practice, we employ advanced diagnostic methods, including:
- Endoscopy and biopsy procedures for tissue sampling.
- Imaging studies to assess the extent of the disease.
- Collaboration with a multidisciplinary medical team to facilitate comprehensive care.
Effective Treatments for MALT Lymphoma
Treatment for MALT lymphoma often begins with eradicating Helicobacter pylori through antibiotic therapy. Additional options may involve:
- R-CHOP chemotherapy, a standard regimen for aggressive lymphomas. The five-year survival rate for patients with gastric lymphoma is approximately 71% in the United States.
- Surveillance strategies for indolent cases.
- Endoscopic approaches for localized treatment.
Managing Diffuse Large B-cell Lymphoma
Difficulties in managing DLBCL highlight the importance of a well-coordinated treatment plan. Our team focuses on:
- Utilizing the R-CHOP regimen combined with comprehensive supportive care.
- Regular follow-ups to monitor treatment effects and adjust therapies as needed.
Recognizing Symptoms of Gastric Lymphoma
Identifying the symptoms of gastric lymphoma early can significantly impact treatment outcomes. Common signs include:
- Persistent abdominal pain and discomfort.
- Nausea and vomiting.
- Unexplained weight loss and appetite changes.
Supportive Care and Follow-up Strategies
Our practice emphasizes the importance of supportive care alongside treatment. This includes:
- Palliative care options to manage symptoms and enhance quality of life.
- Regular monitoring via endoscopy to detect recurrence.
- Patient education to address questions and concerns throughout the treatment journey.
Frequently Asked Questions About Lymphoma Treatment
-
The symptoms may include abdominal pain, nausea, vomiting, weight loss, and changes in appetite.
-
Diagnosis typically involves endoscopy, biopsy, and imaging studies to evaluate the presence and extent of the disease.
-
Treatment options include antibiotic therapy for Helicobacter pylori, chemotherapy options like R-CHOP, and endoscopic interventions.
-
The prognosis can vary based on several factors, including the patient’s overall health and response to treatment. In the United States, the five-year survival rate for stage I non-Hodgkin lymphoma is 87%, decreasing to about 63% for stage IV.
-
Regular follow-up appointments are essential for monitoring your health and managing any potential recurrence of lymphoma.
Why Choose Our Gastroenterology Practice
Choosing our practice ensures you receive care from highly trained professionals like Dr. Mit Shah, MD, and Dr. Davinder Singh, MD, both board-certified in Internal Medicine and Gastroenterology. Dr. Singh, who has significant experience managing complex gastrointestinal disorders, contributes to our commitment to providing comprehensive treatments directed towards achieving optimal health outcomes.
We pride ourselves on our multidisciplinary approach, utilizing advanced technologies and procedures tailored to each patient’s specific needs. Our commitment is supported by years of training and clinical excellence, ensuring a robust framework for personalized care.
About UsTake the First Step Towards Healthier Living in Long Island
If you or a loved one are seeking information about lymphoma of the stomach and its treatment options, reach out to our practice serving Long Island, Queens, and Levittown. With our dedicated team, including Dr. Mit Shah, MD, who serves as Chief of GI at Flushing Hospital Medical Center, you can explore a personalized plan of care designed to meet your needs. Schedule your consultation today to take the first step toward better health.
